Drug intelligence / Profile preview

IodAID

Development stage
Unknown
Lead developer
Abyss Ingredients
Modality
Small Molecules
Administration
Oral
01

Overview

IodAID is a marine-derived nutraceutical ingredient developed by Abyss Ingredients, sourced from the upcycling of North Atlantic brown seaweeds, specifically *Ascophyllum nodosum* and *Fucus vesiculosus*. It is naturally rich in iodine, minerals, fucoidan, and marine polyphenols. While its primary marketed applications include supporting thyroid function, hormonal health, and cognitive performance due to its high iodine content, it also contains bioactive polyphenols that support glycemic health by inhibiting α-amylase and α-glucosidase enzymes. The ingredient is produced via a water-based manufacturing process that concentrates essential minerals while reducing sodium levels, and it is available in both soluble powder and liquid forms for use in oral dietary supplements.

Brand names
IodAID
02

Targets

Sucrase-IsomaltaseAMY (Pancreatic alpha-amylase)

Beyond the preview

Go deeper on IodAID.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IodAID.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call